抗磷脂抗体与复发性缺血性卒中:系统综述与荟萃分析
该系统综述与荟萃分析检索PubMed、EMBASE和Cochrane图书馆1990年以来英文或韩文文献,纳入8项研究共2510例受试者(844例aPL阳性),评估抗磷脂抗体与复发性缺血性卒中的关联。荟萃分析显示aPL对复发性缺血性卒中的相对危险度为1.41(95%CI 0.91-2.17;I2=54%),亚组分析中年龄<50岁、种族和aPL类型均未增加复发性缺血性卒中风险。结论认为aPL并非成人复发性缺血性卒中的独立预测因素。
要点
- aPL与复发性缺血性卒中的相对危险度为1.41(95%CI 0.91-2.17),无统计学显著性。
- 年龄<50岁、种族和aPL类型亚组均未显示增加复发性缺血性卒中风险。
- aPL并非成人复发性缺血性卒中的独立预测因素,但疾病标准不统一需进一步前瞻性研究。
核心结论
- 抗磷脂抗体不是成人复发性缺血性卒中的独立预测因素。
研究设计与样本
- 系统综述与荟萃分析,检索PubMed、EMBASE和Cochrane图书馆1990年以来英文或韩文文献,纳入8项研究共2510例受试者,其中844例aPL阳性。
主要发现
- aPL对复发性缺血性卒中的相对危险度为1.41(95%CI 0.91-2.17;I2=54%)。
- 亚组分析中年龄<50岁、种族和aPL类型均未增加复发性缺血性卒中风险。
关键数值与推荐
- 相对危险度1.41(95%CI 0.91-2.17;I2=54%)。
临床怎么用
- 在成人复发性缺血性卒中风险评估中,不应仅依据aPL阳性判定其为独立预测因素。
局限性
- 疾病标准不统一,需进一步设计良好的前瞻性试验确认。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND PURPOSE: Although aPLs (antiphospholipid antibodies) are associated with thrombotic events, especially in young patients, the role of aPLs in recurrent ischemic strokes (RIS) is unclear. This systematic review and meta-analysis evaluated the association between aPLs and RIS. METHODS: The systematic review was conducted by a computer-assisted search of literature in PubMed, EMBASE, and Cochrane library published in English or Korean from 1990, according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses statement (PRISMA). Review Manager 5.3 software was used for statistical analyses. RESULTS: Of the 2272 identified articles, 8 studies were included (2510 subjects; 844 aPL positive). The meta-analysis revealed a relative risk of aPLs for RIS of 1.41 (95% CI, 0.91-2.17; I2=54%). In the subgroup analysis, age <50 years, ethnicity, and type of aPL did not increase the risk of RIS. CONCLUSIONS: We found that aPLs are not an independent predictor for RIS in adults. However, considering the nonstandardized disease criteria, further well-designed prospective trials should be considered to confirm these findings.
引用
- Kim Y, Kim SY. Antiphospholipid Antibody and Recurrent Ischemic Stroke: A Systematic Review and Meta-Analysis. Stroke. 2020. PMID: 32981458. doi:10.1161/STROKEAHA.120.030431
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。